[1]
Tani, N. et al. 2021. Early responders within seven days of dupilumab treatment for severe asthma evaluated by patient-reported outcome: a pilot study. Multidisciplinary Respiratory Medicine. 16, (Mar. 2021). DOI:https://doi.org/10.4081/mrm.2021.736.